Max Healthcare Institute Limited

NSEI:MAXHEALTH 株式レポート

時価総額:₹971.9b

Max Healthcare Institute マネジメント

マネジメント 基準チェック /24

Max Healthcare Instituteの CEO はAbhay Soiで、 Jun2020年に任命され、 の在任期間は 4.42年です。 の年間総報酬は₹ 247.33Mで、 79.7%給与と20.3%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の23.74%を直接所有しており、その価値は₹ 230.73B 。経営陣と取締役会の平均在任期間はそれぞれ5.1年と3.5年です。

主要情報

Abhay Soi

最高経営責任者

₹247.3m

報酬総額

CEO給与比率79.7%
CEO在任期間4.4yrs
CEOの所有権23.7%
経営陣の平均在職期間5.1yrs
取締役会の平均在任期間3.5yrs

経営陣の近況

Shareholders May Be More Conservative With Max Healthcare Institute Limited's (NSE:MAXHEALTH) CEO Compensation For Now

Sep 14
Shareholders May Be More Conservative With Max Healthcare Institute Limited's (NSE:MAXHEALTH) CEO Compensation For Now

Recent updates

Max Healthcare Institute Limited Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next

Nov 09
Max Healthcare Institute Limited Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next

Shareholders May Be More Conservative With Max Healthcare Institute Limited's (NSE:MAXHEALTH) CEO Compensation For Now

Sep 14
Shareholders May Be More Conservative With Max Healthcare Institute Limited's (NSE:MAXHEALTH) CEO Compensation For Now

Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?

Jul 18
Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?

Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/S Is On The Mark

Jun 21
Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/S Is On The Mark

Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know

May 25
Max Healthcare Institute Limited (NSE:MAXHEALTH) Fell Short of Analyst Expectations: Here's What You Need To Know

Here's Why We Think Max Healthcare Institute (NSE:MAXHEALTH) Might Deserve Your Attention Today

Apr 14
Here's Why We Think Max Healthcare Institute (NSE:MAXHEALTH) Might Deserve Your Attention Today

Max Healthcare Institute Limited's (NSE:MAXHEALTH) Earnings Haven't Escaped The Attention Of Investors

Mar 18
Max Healthcare Institute Limited's (NSE:MAXHEALTH) Earnings Haven't Escaped The Attention Of Investors

Revenue Miss: Max Healthcare Institute Limited Fell 21% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Feb 03
Revenue Miss: Max Healthcare Institute Limited Fell 21% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Rather Sparingly

Jan 08
Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Rather Sparingly

Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Still Appears To Be Reasonable

Dec 18
Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Still Appears To Be Reasonable

With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case

Oct 26
With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case

Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt

Sep 20
Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt

Is Now The Time To Put Max Healthcare Institute (NSE:MAXHEALTH) On Your Watchlist?

Jul 07
Is Now The Time To Put Max Healthcare Institute (NSE:MAXHEALTH) On Your Watchlist?

Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt

Jun 19
Max Healthcare Institute (NSE:MAXHEALTH) Could Easily Take On More Debt

Pinning Down Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Is Difficult Right Now

Apr 11
Pinning Down Max Healthcare Institute Limited's (NSE:MAXHEALTH) P/E Is Difficult Right Now

With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case

Mar 15
With EPS Growth And More, Max Healthcare Institute (NSE:MAXHEALTH) Makes An Interesting Case

Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?

Feb 22
Is Max Healthcare Institute (NSE:MAXHEALTH) A Risky Investment?

Max Healthcare Institute (NSE:MAXHEALTH) Has A Rock Solid Balance Sheet

Nov 22
Max Healthcare Institute (NSE:MAXHEALTH) Has A Rock Solid Balance Sheet

Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Has Caught The Eye Of Investors

Oct 26
Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Has Caught The Eye Of Investors

Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Quite Sensibly

Jul 15
Max Healthcare Institute (NSE:MAXHEALTH) Seems To Use Debt Quite Sensibly

Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Can Manage Its Debt Responsibly

Mar 09
Here's Why Max Healthcare Institute (NSE:MAXHEALTH) Can Manage Its Debt Responsibly

Max Healthcare Institute's (NSE:MAXHEALTH) Solid Profits Have Weak Fundamentals

Nov 24
Max Healthcare Institute's (NSE:MAXHEALTH) Solid Profits Have Weak Fundamentals

CEO報酬分析

Max Healthcare Institute の収益と比較して、Abhay Soi の報酬はどのように変化したか?
日付総報酬給与会社業績
Sep 30 2024n/an/a

₹11b

Jun 30 2024n/an/a

₹11b

Mar 31 2024₹247m₹197m

₹11b

Dec 31 2023n/an/a

₹11b

Sep 30 2023n/an/a

₹10b

Jun 30 2023n/an/a

₹12b

Mar 31 2023₹140m₹140m

₹11b

Dec 31 2022n/an/a

₹10b

Sep 30 2022n/an/a

₹9b

Jun 30 2022n/an/a

₹6b

Mar 31 2022₹140m₹49m

₹6b

Dec 31 2021n/an/a

₹6b

Sep 30 2021n/an/a

₹5b

Jun 30 2021n/an/a

₹3b

Mar 31 2021₹117m₹91m

-₹1b

報酬と市場: Abhayの 総報酬 ($USD 2.93M ) は、 Indian市場 ($USD 1.10M ) の同規模の企業の平均を上回っています。

報酬と収益: Abhayの報酬は過去 1 年間で 20% 以上増加しました。


CEO(最高経営責任者

Abhay Soi (51 yo)

4.4yrs

在職期間

₹247,330,308

報酬

Mr. Abhay Soi is a Co-Founder of Halcyon Group. He served as Executive Officer at Ernst & Young LLP. Mr. Soi served as Head of Financial Restructuring group at Ernst & Young and Arthur Anderson.He has in-...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Abhay Soi
Chairman & MD4.4yrs₹247.33m23.74%
₹ 230.7b
Yogesh Sareen
Senior Director & CFO12.8yrs₹45.10m0.0062%
₹ 60.0m
Dhiraj Aroraa
Senior VP1.8yrs₹10.00mデータなし
Mradul Kaushik
Member of Group Medical Advisory Councilno dataデータなしデータなし
Prashant Singh
Director of Information Technology & Chief Information Officer5.2yrsデータなしデータなし
Gagan Palta
General Counsel & Directorless than a yearデータなしデータなし
Anas Wajid
Senior Director and Chief Sales & Marketing Officerno dataデータなしデータなし
Umesh Gupta
Member of Group Medical Advisory Council5.3yrsデータなしデータなし
Sandeep Budhiraja
Member of Group Medical Advisory Council & Group Medical Directorno dataデータなしデータなし
Sanjiv K. Marya
Member of Group Medical Advisory Council5.1yrsデータなしデータなし
Anurag Krishna
Chairman of Paediatrics & Paediatric Surgery3.8yrsデータなしデータなし
Harinder Chehal
Senior Director & COO - Cluster 25.3yrsデータなしデータなし

5.1yrs

平均在職期間

54yo

平均年齢

経験豊富な経営陣: MAXHEALTHの経営陣は経験豊富で経験豊富です(平均在職期間は5.1年)。


取締役

名称ポジション在職期間報酬所有権
Abhay Soi
Chairman & MD5.4yrs₹247.33m23.74%
₹ 230.7b
Mradul Kaushik
Member of Group Medical Advisory Councilno dataデータなしデータなし
Gagan Palta
General Counsel & Directorless than a yearデータなしデータなし
Umesh Gupta
Member of Group Medical Advisory Councilno dataデータなしデータなし
Sandeep Budhiraja
Member of Group Medical Advisory Council & Group Medical Directorno dataデータなしデータなし
Sanjiv K. Marya
Member of Group Medical Advisory Councilno dataデータなしデータなし
N. Venkatesan
Director & Chief Procurement Officerno dataデータなしデータなし
Mahendra Lodha
Non-Executive Independent Director5.4yrs₹5.25mデータなし
Narayan Seshadri
Non-Executive Non-Independent Director1.5yrs₹3.83mデータなし
Pradeep Chowbey
Member of Group Medical Advisory Councilno data₹4.42mデータなし
Harit Chaturvedi
Member of Group Medical Advisory Councilno dataデータなしデータなし
Dinesh Khullar
Member of Group Medical Advisory Councilno dataデータなしデータなし

3.5yrs

平均在職期間

57.5yo

平均年齢

経験豊富なボード: MAXHEALTHの 取締役会経験豊富 であると考えられます ( 3.5年の平均在任期間)。